| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Nutrition and Biochemistry, University of Montréal (W.E.-A., J.B., M.-L.P., C.N., R.R., S.H., E.J., M.P.), and Department of Surgery, McGill University (L.R.), Montréal, Québec, Canada H2L 4MI; and Department of Pediatrics (G.D.) American University of Beirut, 113/6044, B21 Beirut, Lebanon
Address all correspondence and requests for reprints to: Dr. Marc Prentki, CR-CHUM, Pavillon de Sève, Y4603, 1560 Sherbrooke East, Montreal, Quebec, Canada H2L 4M1. E-mail: marc.prentki{at}umontreal.ca.
We have proposed the "glucolipotoxicity" hypothesis in which elevated free fatty acids (FFAs) together with hyperglycemia are synergistic in causing islet ß-cell damage because high glucose inhibits fat oxidation and consequently lipid detoxification. The effects of 12 d culture of both rat INS 832/13 cells and human islet ß-cells were investigated in medium containing glucose (5, 11, 20 mM) in the presence or absence of various FFAs. A marked synergistic effect of elevated concentrations of glucose and saturated FFA (palmitate and stearate) on inducing ß-cell death by apoptosis was found in both INS 832/13 and human islet ß-cells. In comparison, linoleate (polyunsaturated) synergized only modestly with high glucose, whereas oleate (monounsaturated) was not toxic. Treating cells with the acyl-coenzyme A synthase inhibitor triacsin C, or the AMP kinase activators metformin and 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside that redirect lipid partitioning to oxidation, curtailed glucolipotoxicity. In contrast, the fat oxidation inhibitor etomoxir, like glucose, markedly enhanced palmitate-induced cell death. The data indicate that FFAs must be metabolized to long chain fatty acyl-CoA to exert toxicity, the effect of which can be reduced by activating fatty acid oxidation. The results support the glucolipotoxicity hypothesis of ß-cell failure proposing that elevated FFAs are particularly toxic in the context of hyperglycemia.
This article has been cited by other articles:
![]() |
S.-E Choi, S.-M. Lee, Y.-J. Lee, L.-J. Li, S.-J. Lee, J.-H. Lee, Y. Kim, H.-S. Jun, K.-W. Lee, and Y. Kang Protective Role of Autophagy in Palmitate-Induced INS-1 {beta}-Cell Death Endocrinology, January 1, 2009; 150(1): 126 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Stoddart, N. J. Smith, and G. Milligan International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions Pharmacol. Rev., December 1, 2008; 60(4): 405 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Cunha, P. Hekerman, L. Ladriere, A. Bazarra-Castro, F. Ortis, M. C. Wakeham, F. Moore, J. Rasschaert, A. K. Cardozo, E. Bellomo, et al. Initiation and execution of lipotoxic ER stress in pancreatic {beta}-cells J. Cell Sci., July 15, 2008; 121(14): 2308 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poitout and R. P. Robertson Glucolipotoxicity: Fuel Excess and {beta}-Cell Dysfunction Endocr. Rev., May 1, 2008; 29(3): 351 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Leekumjorn, Y. Wu, A. K. Sum, and C. Chan Experimental and Computational Studies Investigating Trehalose Protection of HepG2 Cells from Palmitate-Induced Toxicity Biophys. J., April 1, 2008; 94(7): 2869 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lai, G. Bikopoulos, M. B. Wheeler, M. Rozakis-Adcock, and A. Volchuk Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic {beta}-cells Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E540 - E550. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Donath, D. M. Schumann, M. Faulenbach, H. Ellingsgaard, A. Perren, and J. A. Ehses Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy Diabetes Care, February 1, 2008; 31(Supplement_2): S161 - S164. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diakogiannaki, S. Dhayal, C. E Childs, P. C Calder, H. J Welters, and N. G Morgan Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic {beta}-cells J. Endocrinol., August 1, 2007; 194(2): 283 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. Xu, S. Zhang, L. Yan, C. Yang, W. Lu, Y. Li, and H. Cheng The role of G protein-coupled receptor 40 in lipoapoptosis in mouse {beta}-cell line NIT-1 J. Mol. Endocrinol., June 1, 2007; 38(6): 651 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Flowers, M. E. Rabaglia, K. L. Schueler, M. T. Flowers, H. Lan, M. P. Keller, J. M. Ntambi, and A. D. Attie Loss of Stearoyl-CoA Desaturase-1 Improves Insulin Sensitivity in Lean Mice but Worsens Diabetes in Leptin-Deficient Obese Mice Diabetes, May 1, 2007; 56(5): 1228 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mussmann, M. Geese, F. Harder, S. Kegel, U. Andag, A. Lomow, U. Burk, D. Onichtchouk, C. Dohrmann, and M. Austen Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells J. Biol. Chem., April 20, 2007; 282(16): 12030 - 12037. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E549 - E560. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Borradaile, X. Han, J. D. Harp, S. E. Gale, D. S. Ory, and J. E. Schaffer Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death J. Lipid Res., December 1, 2006; 47(12): 2726 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nolan, M. S.R. Madiraju, V. Delghingaro-Augusto, M.-L. Peyot, and M. Prentki Fatty Acid Signaling in the {beta}-Cell and Insulin Secretion Diabetes, December 1, 2006; 55(Supplement_2): S16 - S23. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wente, A. M. Efanov, M. Brenner, A. Kharitonenkov, A. Koster, G. E. Sandusky, S. Sewing, I. Treinies, H. Zitzer, and J. Gromada Fibroblast Growth Factor-21 Improves Pancreatic {beta}-Cell Function and Survival by Activation of Extracellular Signal-Regulated Kinase 1/2 and Akt Signaling Pathways Diabetes, September 1, 2006; 55(9): 2470 - 2478. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A Walz, L. Harndahl, N. Wierup, E. Zmuda-Trzebiatowska, F. Svennelid, V. C Manganiello, T. Ploug, F. Sundler, E. Degerman, B. Ahren, et al. Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B. J. Endocrinol., June 1, 2006; 189(3): 629 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Jensen Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B13 - B19. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ravnskjaer, M. Boergesen, L. T Dalgaard, and S. Mandrup Glucose-induced repression of PPAR{alpha} gene expression in pancreatic {beta}-cells involves PP2A activation and AMPK inactivation. J. Mol. Endocrinol., April 1, 2006; 36(2): 289 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Rachek, N. P. Thornley, V. I. Grishko, S. P. LeDoux, and G. L. Wilson Protection of INS-1 Cells From Free Fatty Acid-Induced Apoptosis by Targeting hOGG1 to Mitochondria. Diabetes, April 1, 2006; 55(4): 1022 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Staiger, N. Stefan, H. Staiger, M. D. Brendel, D. Brandhorst, R. G. Bretzel, F. Machicao, M. Kellerer, M. Stumvoll, A. Fritsche, et al. Adiponectin Is Functionally Active in Human Islets but Does Not Affect Insulin Secretory Function or {beta}-Cell Lipoapoptosis J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6707 - 6713. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hu, J. T. Deeney, C. J. Nolan, M.-L. Peyot, A. Ao, A. M. Richard, E. Luc, N. J. Faergeman, J. Knudsen, W. Guo, et al. Regulation of lipolytic activity by long-chain acyl-coenzyme A in islets and adipocytes Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1085 - E1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Donath, J. A. Ehses, K. Maedler, D. M. Schumann, H. Ellingsgaard, E. Eppler, and M. Reinecke Mechanisms of {beta}-Cell Death in Type 2 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S108 - S113. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Busch, E. Gurisik, D. V. Cordery, M. Sudlow, G. S. Denyer, D. R. Laybutt, W. E. Hughes, and T. J. Biden Increased Fatty Acid Desaturation and Enhanced Expression of Stearoyl Coenzyme A Desaturase Protects Pancreatic {beta}-Cells from Lipoapoptosis Diabetes, October 1, 2005; 54(10): 2917 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kjorholt, M. C. Akerfeldt, T. J. Biden, and D. R. Laybutt Chronic Hyperglycemia, Independent of Plasma Lipid Levels, Is Sufficient for the Loss of {beta}-Cell Differentiation and Secretory Function in the db/db Mouse Model of Diabetes Diabetes, September 1, 2005; 54(9): 2755 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ravnskjaer, M. Boergesen, B. Rubi, J. K. Larsen, T. Nielsen, J. Fridriksson, P. Maechler, and S. Mandrup Peroxisome Proliferator-Activated Receptor {alpha} (PPAR{alpha}) Potentiates, whereas PPAR{gamma} Attenuates, Glucose-Stimulated Insulin Secretion in Pancreatic {beta}-Cells Endocrinology, August 1, 2005; 146(8): 3266 - 3276. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hull, Z.-P. Shen, M. R. Watts, K. Kodama, D. B. Carr, K. M. Utzschneider, S. Zraika, F. Wang, and S. E. Kahn Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Islet Amyloid Deposition in Mice Expressing the Gene for Human Islet Amyloid Polypeptide Diabetes, July 1, 2005; 54(7): 2235 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramasamy, S. J. Vannucci, S. S. D. Yan, K. Herold, S. F. Yan, and A. M. Schmidt Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology, July 1, 2005; 15(7): 16R - 28R. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oh, B. A. Spurlin, J. E. Pessin, and D. C. Thurmond Munc18c Heterozygous Knockout Mice Display Increased Susceptibility for Severe Glucose Intolerance Diabetes, March 1, 2005; 54(3): 638 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-y. Wang and R. H. Unger Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E216 - E221. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Leclerc and G. A. Rutter AMP-Activated Protein Kinase: A New Beta-Cell Glucose Sensor?: Regulation by Amino Acids and Calcium Ions Diabetes, December 1, 2004; 53(suppl_3): S67 - S74. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Moore, M. A. Ugas, D. K. Hagman, S. D. Parazzoli, and V. Poitout Evidence Against the Involvement of Oxidative Stress in Fatty Acid Inhibition of Insulin Secretion Diabetes, October 1, 2004; 53(10): 2610 - 2616. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poitout {beta}-Cell Lipotoxicity: Burning Fat into Heat? Endocrinology, August 1, 2004; 145(8): 3563 - 3565. [Full Text] [PDF] |
||||
![]() |
M.-L. Peyot, C. J. Nolan, K. Soni, E. Joly, R. Lussier, B. E. Corkey, S. P. Wang, G. A. Mitchell, and M. Prentki Hormone-Sensitive Lipase Has a Role in Lipid Signaling for Insulin Secretion but Is Nonessential for the Incretin Action of Glucagon-Like Peptide 1 Diabetes, July 1, 2004; 53(7): 1733 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ceriello and E. Motz Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 816 - 823. [Abstract] [Full Text] |
||||
![]() |
R. Roduit, C. Nolan, C. Alarcon, P. Moore, A. Barbeau, V. Delghingaro-Augusto, E. Przybykowski, J. Morin, F. Masse, B. Massie, et al. A Role for the Malonyl-CoA/Long-Chain Acyl-CoA Pathway of Lipid Signaling in the Regulation of Insulin Secretion in Response to Both Fuel and Nonfuel Stimuli Diabetes, April 1, 2004; 53(4): 1007 - 1019. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |